EBM
vs
S
S&P TSX Composite Index (Canada)
EBM
Over the past 12 months, EBM has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +91% compared to the S&P TSX Composite Index (Canada)'s +27% growth.
Stocks Performance
EBM vs S&P TSX Composite Index (Canada)
Performance Gap
EBM vs S&P TSX Composite Index (Canada)
Performance By Year
EBM vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Eastwood Bio-Medical Canada Inc
Glance View
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.
